Results 191 to 200 of about 83,877 (250)
Some of the next articles are maybe not open access.
New insights into IVIg mechanisms and alternatives in autoimmune and inflammatory diseases
Current opinion in hematology, 2020Purpose of review Intravenous immunoglobulin (IVIg) is an effective treatment for an increasing number of autoimmune and inflammatory conditions. However, IVIg continues to be limited by problems of potential shortages and cost.
P. Norris, Gurleen Kaur, A. Lazarus
semanticscholar +1 more source
New England Journal of Medicine, 2012
Intravenous immune globulin (IVIG) is therapeutic in a number of situations. However, it contains antibodies that may react with the recipient's tissues to produce a variety of autoimmune manifestations. Hemolytic anemia is a dramatic, but rare sequela of IVIG administration.
Sofya, Pintova +2 more
exaly +3 more sources
Intravenous immune globulin (IVIG) is therapeutic in a number of situations. However, it contains antibodies that may react with the recipient's tissues to produce a variety of autoimmune manifestations. Hemolytic anemia is a dramatic, but rare sequela of IVIG administration.
Sofya, Pintova +2 more
exaly +3 more sources
Archivum Immunologiae et Therapiae Experimentalis, 2016
Anaphylactic reactions are a known complication in some IgA-deficient patients receiving blood or plasma transfusions. It is of particular interest that anaphylaxis has been observed in patients with common variable immunodeficiency (CVID) who are receiving intravenous gammaglobulin (IVIG), and in that, although these patients have an impaired response
Sharon Julie, Williams, Sudhir, Gupta
openaire +2 more sources
Anaphylactic reactions are a known complication in some IgA-deficient patients receiving blood or plasma transfusions. It is of particular interest that anaphylaxis has been observed in patients with common variable immunodeficiency (CVID) who are receiving intravenous gammaglobulin (IVIG), and in that, although these patients have an impaired response
Sharon Julie, Williams, Sudhir, Gupta
openaire +2 more sources
Lupus, 2004
For more than two decades, the intravenous administration of high doses of IgG pooled from the plasma of healthy donors (immune globulin therapy, also known as ‘IVIG’) has benefited patients with a variety of autoimmune disorders. A potential therapeutic role of IVIG in the prevention of thrombosis and of miscarriages in antiphospholipid syndrome (APS)
TRIOLO, Giovanni +7 more
openaire +3 more sources
For more than two decades, the intravenous administration of high doses of IgG pooled from the plasma of healthy donors (immune globulin therapy, also known as ‘IVIG’) has benefited patients with a variety of autoimmune disorders. A potential therapeutic role of IVIG in the prevention of thrombosis and of miscarriages in antiphospholipid syndrome (APS)
TRIOLO, Giovanni +7 more
openaire +3 more sources
Allergy: European Journal of Allergy and Clinical Immunology, 2003
Intravenous immunoglobulin (IVIG) preparations are fractionated from a plasma pool of several thousand donors. IVIG contain immune antibodies and physiologic autoantibodies. Immune antibodies reflect the immunologic experience of the donor population. This fraction of IVIG preparations is useful for replacement therapy and passive immunisation. Natural
H U, Simon, P J, Späth
exaly +3 more sources
Intravenous immunoglobulin (IVIG) preparations are fractionated from a plasma pool of several thousand donors. IVIG contain immune antibodies and physiologic autoantibodies. Immune antibodies reflect the immunologic experience of the donor population. This fraction of IVIG preparations is useful for replacement therapy and passive immunisation. Natural
H U, Simon, P J, Späth
exaly +3 more sources
Sialic acid–IVIg targeting CD22
Blood, 2010In this issue of Blood , Seite and colleagues report their findings on human tonsil B cells and human Ramos B-cell lymphoma line apoptosis, induced by sialic acid–intravenous immunoglobulin (SA-IVIg) fraction.[1][1] IVIg is used for treatment of many inflammatory, autoimmune, and immune-
Miri, Blank, Yehuda, Shoenfeld
openaire +2 more sources
Comparison of IVIG resistance predictive models in Kawasaki disease
Pediatric Research, 2021U. Kaya Akca +11 more
semanticscholar +1 more source
IVIg conducts DC-platelet nuptials
Blood, 2010The anti-inflammatory effects of IVIg have been adoptively transferred using IVIg-primed cells in autoimmunity and inflammatory states (reviewed in Crow et al[1][1] and Lazarus[2][2]). Although dendritic cells (DCs) have entered the spotlight in this process, the downstream target of these cells ...
openaire +2 more sources
Neurology, 2007
IV immunoglobulin (IVIG) is a widely accepted treatment for autoimmune myasthenia gravis (MG), usually utilized in rapidly progressive or exacerbating disease.1 As with many MG treatments, evidence-based support of its efficacy is scarce and not entirely definitive.
openaire +1 more source
IV immunoglobulin (IVIG) is a widely accepted treatment for autoimmune myasthenia gravis (MG), usually utilized in rapidly progressive or exacerbating disease.1 As with many MG treatments, evidence-based support of its efficacy is scarce and not entirely definitive.
openaire +1 more source